Tampa General Hospital Selects Palantir’s AI Software to Power Connected Care Coordination, Extending Long-Term Partnership

Published: Jun 5, 2024

Palantir AIP will serve as the core analytics and AI platform for Tampa General Hospital’s vision for care coordination. AI-powered workflows for bed placement, patient itineraries, and staffing allocation have already shown drastic improvements in patient care, sharply reducing patient waiting time and length of stay.

TAMPA, Fla. & DENVER--(June 5, 2024) — Tampa General Hospital (TGH) and Palantir Technologies Inc. (NYSE: PLTR) ("Palantir"), a leading builder of artificial intelligence (AI) systems for the health care sector and the modern enterprise, today announced a significant step forward in their long-term partnership to deliver on an ambitious vision for the future of AI in health care.

Tampa General, one of the nation’s leading academic health systems, plans to deploy Palantir’s Artificial Intelligence Platform (AIP) to deliver a Care Coordination Operating System, which will securely encode Tampa General’s domain expertise, real-time situational awareness, and large-language models into decision-support tools to power eligibility and prioritization workflows for frontline teams across all aspects of care operations. TGH will also leverage this platform to bring automation to other system workflows, including streamlining revenue cycle management.


Tampa General will use AIP to encode its clinical expertise into eligibility and prioritization decisions on the frontlines, to ensure patients receive the right care in the right place as quickly and safely possible. Its new Hospital Sync application suite and insights, powered by Palantir software, aims to set the standard for optimal care coordination nationwide.


Tampa General Hospital and Palantir Technologies started working together in 2021, when TGH implemented Palantir’s Foundry software to revolutionize health care management, optimize operational efficiency and enhance patient outcomes. Since then, Tampa General has expanded its use of Palantir’s software from one to more than a dozen use cases across the health system, contributing to meaningful, measurable improvements in patient care. For example, Tampa General cut by 83% the amount of time required to place patients and post anesthesia care unit (PACU) holds declined 28%. In addition, the mean length of stay for sepsis patients went down 30%.


“We are on a mission to transform health care through innovation, and Palantir’s technology platforms enable us to leverage data to improve quality and strengthen our operations,” said John Couris, president and CEO of Tampa General Hospital. “Less time waiting for placement and a reduced length of stay does not just enhance the patient experience, it gives us an opportunity to treat more patients that need care. These improvements, powered by data and technology, contribute to better and more robust treatment plans, which in turn, can lead to better patient outcomes.”


“Our partnership is proving that software is vital for overcoming many of the most pressing healthcare challenges that we collectively face,” said Alex Karp, co-founder and chief executive officer of Palantir Technologies Inc. “Tampa General has become an industry leader in leveraging technology to deliver even further improvements in patient care.”


Palantir’s engineers will continue working closely with Tampa General’s operations, analytics, and clinical subject matter experts as part of this next phase. In addition to the expanded partnership, Palantir will be joining the Tampa Medical and Research District, which boasts a variety of health care organizations from academics and clinical care to research and biotechnology, in the heart of Tampa Bay. The District, which is anchored by Tampa General and the University of South Florida Morsani College of Medicine, is the driving force behind Tampa’s growing reputation as a global destination for world-class care.


Learn more about how Palantir is driving next-generation operations and outcomes for health systems.


Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.